IRF4 and Miyoshi myopathy: A more recent study in relapsed/refractory MM demonstrated that omacetaxine synergises with immunomodulatory drugs, causing substantial downregulation of the oncoproteins interferon regulatory factor 4 (IRF4) and MYC [249].